Loading...

OpGen, Inc.

OPGN•NASDAQ
Healthcare
Medical - Diagnostics & Research
$0.00
$0.00(0.00%)

OpGen, Inc. (OPGN) Stock Overview

Explore OpGen, Inc.’s financial performance, market position, analyst ratings, and future outlook.

Meyka AI Score

B

Score: 65.1/100

Key Financials

Market Cap1K
P/E Ratio0.00
EPS (TTM)$-15.53
ROE-1.18%
Fundamental Analysis

AI Price Forecasts

1 Week$4.49
1 Month$4.78
3 Months$27.82
1 Year Target$0.65

OPGN Stock Analysis & Investment Overview

Our comprehensive AI-powered analysis of OpGen, Inc. (OPGN) provides investors with deep insights into the stock's performance, growth potential, and market positioning. With a Meyka AI Score of B, this stock demonstrates moderate investment characteristics based on our advanced machine learning models.

The current technical analysis reveals key indicators including an RSI of 17.83, suggesting the stock is in an oversold condition. Our forecasting models predict significant price movements, with a 12-month target of $0.65.

Key financial metrics showcase the company's fundamental strength, including a P/E ratio of 0.00 and a market capitalization of 1K. These metrics, combined with our AI analysis, provide a comprehensive view for both institutional and retail investors.

1-Day Change
-10.67%
5-Day Change
-16.25%
1-Month Change
386.92%
3-Month Change
324.05%
6-Month Change
83.06%
Year-to-Date (YTD) Change
532.08%
1-Year Change
-52.14%
3-Year Change
-97.58%
5-Year Change
-99.30%
All-Time (Max) Change
-100.00%

Contact Information

https://www.opgen.com
240 813 1260
9717 Key West Avenue, Rockville, MD, 20850

Company Facts

85 Employees
IPO DateMay 5, 2015
CountryUS
Actively Trading

Frequently Asked Questions

;